EA3132: Phase II Randomized Trial of Radiotherapy with or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing

For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT02501954

Contact name

Steven Schmitt

Clinical trials study type

Oncology - Head and Neck

Clinical trials trial status

Open to Accrual

IRB number

1342138

Principal investigator

Mei Tang, MD

Clinical trials study number

EA3132

Phone

443-849-3285

Clinical trials title (full)

EA3132: Phase II Randomized Trial of Radiotherapy with or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing